RENOVORX, INC. Operating Income
RENOVORX, INC. (RNXT) reported Operating Income of -$3.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- RENOVORX, INC. operating income (loss) for the quarter ending 2026-06-30 was -$3.35M.
- RENOVORX, INC. operating income (loss) for the quarter ending 2026-03-31 was -$3.47M.
- RENOVORX, INC. operating income (loss) for the quarter ending 2025-12-31 was -$3.52M.
- RENOVORX, INC. operating income (loss) for the quarter ending 2025-09-30 was -$3.20M.
- RENOVORX, INC. operating income (loss) for fiscal 2025 was -$12.51M.
- RENOVORX, INC. operating income (loss) for fiscal 2024 was -$10.97M.
- RENOVORX, INC. operating income (loss) for fiscal 2023 was -$11.40M.
- RENOVORX, INC. operating income (loss) for fiscal 2022 was -$9.95M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.35M 10-Q · filed 2026-08-13 | -$6.82M 10-Q · filed 2026-08-13 | -$10.34M derived: sum of 3 quarters · filed 2026-08-13 | -$13.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$3.47M 10-Q · filed 2026-05-14 | -$6.99M derived: sum of 2 quarters · filed 2026-05-14 | -$10.19M derived: sum of 3 quarters · filed 2026-05-14 | -$12.87M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$6.72M derived: sum of 2 quarters · filed 2026-03-30 | -$9.40M derived: sum of 3 quarters · filed 2026-08-13 | -$12.51M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$3.20M 10-Q · filed 2025-11-13 | -$5.88M derived: sum of 2 quarters · filed 2026-08-13 | -$8.99M 10-Q · filed 2025-11-13 | -$11.62M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$2.68M 10-Q · filed 2026-08-13 | -$5.79M 10-Q · filed 2026-08-13 | -$8.42M derived: sum of 3 quarters · filed 2026-08-13 | -$11.25M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$3.11M 10-Q · filed 2026-05-14 | -$5.74M derived: sum of 2 quarters · filed 2026-05-14 | -$8.57M derived: sum of 3 quarters · filed 2026-05-14 | -$11.60M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.46M derived: sum of 2 quarters · filed 2026-03-30 | -$8.49M derived: sum of 3 quarters · filed 2026-03-30 | -$10.97M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$2.83M 10-Q · filed 2025-11-13 | -$5.86M derived: sum of 2 quarters · filed 2025-11-13 | -$8.34M 10-Q · filed 2025-11-13 | -$10.12M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$3.03M 10-Q · filed 2025-08-14 | -$5.51M 10-Q · filed 2025-08-14 | -$7.29M derived: sum of 3 quarters · filed 2025-08-14 | -$10.27M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.48M 10-Q · filed 2025-05-15 | -$4.25M derived: sum of 2 quarters · filed 2025-05-15 | -$7.24M derived: sum of 3 quarters · filed 2025-05-15 | -$10.61M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$4.76M derived: sum of 2 quarters · filed 2025-04-01 | -$8.13M derived: sum of 3 quarters · filed 2025-04-01 | -$11.40M 10-K · filed 2025-04-01 |
| 2023-09-30 | -$2.98M 10-Q · filed 2024-11-13 | -$6.36M derived: sum of 2 quarters · filed 2024-11-13 | -$9.62M 10-Q · filed 2024-11-13 | -$11.79M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$3.38M 10-Q · filed 2024-08-13 | -$6.64M 10-Q · filed 2024-08-13 | -$8.81M derived: sum of 3 quarters · filed 2024-08-13 | -$10.97M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$3.26M 10-Q · filed 2024-05-10 | -$5.43M derived: sum of 2 quarters · filed 2024-05-10 | -$7.59M derived: sum of 3 quarters · filed 2024-05-10 | -$10.21M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$4.33M derived: sum of 2 quarters · filed 2024-04-01 | -$6.95M derived: sum of 3 quarters · filed 2024-04-01 | -$9.95M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$2.16M 10-Q · filed 2023-11-13 | -$4.78M derived: sum of 2 quarters · filed 2023-11-13 | -$7.78M 10-Q · filed 2023-11-13 | -$10.14M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$2.61M 10-Q · filed 2023-08-16 | -$5.62M 10-Q · filed 2023-08-16 | -$7.97M derived: sum of 3 quarters · filed 2023-08-16 | -$9.37M derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | -$3.00M 10-Q · filed 2023-05-12 | -$5.36M derived: sum of 2 quarters · filed 2023-05-12 | -$6.76M derived: sum of 3 quarters · filed 2023-05-12 | -$7.62M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.75M derived: sum of 2 quarters · filed 2023-03-31 | -$4.62M derived: sum of 3 quarters · filed 2023-03-31 | -$5.67M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$1.40M 10-Q · filed 2022-11-14 | -$2.26M derived: sum of 2 quarters · filed 2022-11-14 | -$3.31M 10-Q · filed 2022-11-14 | -$3.95M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$866.00K 10-Q · filed 2022-08-12 | -$1.92M 10-Q · filed 2022-08-12 | -$2.56M derived: sum of 3 quarters · filed 2022-08-12 | -$3.47M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$1.05M 10-Q · filed 2022-05-13 | -$1.69M derived: sum of 2 quarters · filed 2022-05-13 | -$2.60M derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$1.55M derived: sum of 2 quarters · filed 2022-03-30 | -$3.20M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$910.00K 10-Q · filed 2021-11-15 | -$2.56M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |